Loading clinical trials...
Loading clinical trials...
A Phase I/II Study Evaluating The Efficacy OF 5-Azacitidine And Bevacizumab In Advanced Renal Cell Carcinoma
Conditions
Interventions
Bevacizumab
Azacitidine
Locations
2
United States
University of Kansas Medical Center
Kansas City, Kansas, United States
Stormont-Vail Cotton O'Neil Cancer Center
Topeka, Kansas, United States
Start Date
June 1, 2009
Primary Completion Date
November 1, 2015
Completion Date
November 1, 2015
Last Updated
June 14, 2017
NCT07485114
NCT06391099
NCT05738694
NCT07227402
NCT06349642
NCT07300241
Lead Sponsor
University of Kansas Medical Center
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions